- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03379350
The Impacts of Intermittent Chest Tube Clamping on Chest Tube Drainage Duration and Postoperative Hospital Stay After Lung Cancer Surgery
The Impacts of Intermittent Chest Tube Clamping on Chest Tube Drainage Duration and Postoperative Hospital Stay After Lung Cancer Surgery: A Prospective Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All patients undergo lateral thoracotomy or video-assisted thoracoscopic surgery (VATS) and are operated on by the same thoracic surgical team. At the end of operation, the lung parenchyma is submerged in sterile saline to test for air leakage, and a single 24-Fr chest tube is placed in each patient. All patients are managed with gravity drainage (water seal only, without suction) on the day of operation.
Once a radiograph is confirmed re-expansion of the lung on the morning of the first postoperative day and no air leak is detected, the patient is a candidate for inclusion in the trial. Eligible patients are randomized to control group or clamping group before 3pm on the postoperative day.
Patients in control group are managed with gravity drainage unchangeably, while patients in clamping group are managed with clamping protocol after 3pm on the postoperative day as follow: the chest tube will be clamped, and the nurses will check the patient every 6 h. If the patient has no problems with compliance, the clamp will be removed for half an hour in the morning to record the drainage volume every 24 h. If patients develops intolerable abnormal symptoms, such as dyspnea, pneumothorax, and severe subcutaneous emphysema after chest tube clamping, the clamp will be removed for 30 min and be reapplied after the symptoms have been resolved. Such patients will be placed under more rigorous surveillance after re-clamping, which requires the medical staff to check on the patients every 2-4 hours in order to promptly detect abnormal symptoms. If abnormal symptoms occur frequently, this clamping protocol will be continued until another radiograph excluded the presence of pneumothorax.
The daily output of pleural fluid was recorded. The criteria for chest tube removal were as follows: (a) drainage volume≤250 mL in 24 h, (b) absence of air leakage and intrathoracic hemorrhage, and (c) absence of signs of purulent pleural effusion and atelectasis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100142
- Beijing Cancer Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Pathological diagnosis of lung cancer Treated with lobectomy and systematic mediastinal lymph node dissection/ systematic sampling Managed with gravity drainage (water seal only, without suction) Re-expansion of the lung confirmed on the morning of the first postoperative day
Exclusion Criteria:
Thoracic cavity infection Prolonged air leakage Reoperation due to chylothorax Atelectasis Liver cirrhosis Renal insufficiency Wound infection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: clamping group
Clamping group are managed with clamping protocol after 3pm on the postoperative day as follow: the chest tube will be clamped, and the nurses will check the patient every 6 h.
If the patient has no problems with compliance, the clamp will be removed for half an hour in the morning to record the drainage volume every 24 h.
|
Clamping group are managed with clamping protocol after 3pm on the postoperative day as follow: the chest tube will be clamped, and the nurses will check the patient every 6 h.
If the patient has no problems with compliance, the clamp will be removed for half an hour in the morning to record the drainage volume every 24 h.
|
No Intervention: control group
Patients in control group are managed with gravity drainage (water seal only, without suction) all the time after operation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
chest tube drainage duration
Time Frame: From date of operation until the date of chest tube removal, assessed up to 10 days
|
time from operation day to the day of chest tube removal
|
From date of operation until the date of chest tube removal, assessed up to 10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative hospital stay
Time Frame: From date of operation until the date of hospital discharge, assessed up to 2 weeks
|
time from opertion day to the day of hospital discharge
|
From date of operation until the date of hospital discharge, assessed up to 2 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
decrease of hemoglobin level
Time Frame: postoperative day 1, before hosptital discharge and 1 month after the operation
|
the decrease of hemoglobin on the first postoperative day and before discharge and a month after surgery
|
postoperative day 1, before hosptital discharge and 1 month after the operation
|
decrease of serum albumin level
Time Frame: postoperative day 1, before hosptital discharge and 1 month after the operation
|
the decrease of serum albumin on the first postoperative day and before discharge and a month after surgery
|
postoperative day 1, before hosptital discharge and 1 month after the operation
|
pleural effusion thickness
Time Frame: observed through CT scan 1 month after the operation
|
pleural effusion thickness showed on the CT scan a month after operation
|
observed through CT scan 1 month after the operation
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10574
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Management of Lung Cancer Patients
-
Heart Care FoundationCompletedManagement and Epidemiology of Patients Admitted in ICUItaly
-
Centre Francois BaclesseLigue contre le cancer, FranceCompletedManagement of Oral Care and Cancer in Palliative SituationFrance
-
Xinjiang Medical UniversityCompletedTo Explore the Influence of CRRT Nursing Team Management Plan on the Prognosis of SAKI PatientsChina
-
Heidelberg UniversityWithdrawnDistress in Caregivers of Cancer Patients
-
Sun Yat-sen UniversityRecruitingApplication of Digital Therapeutic in Lung Cancer Whole Process ManagementChina
-
Assiut UniversityNot yet recruitingFigure Out the Best Method of Fixation for Management of Patients With Diabetic Fracture AnkleEgypt
-
Mayo ClinicLivaNovaCompletedManagement of AnticoagulationUnited States
-
Shanghai Tong Ren HospitalRecruitingTo Explore Whether the Application of Intelligent Hypertension Management System Can Effectively Reduce Blood Pressure in Hypertensive PatientsChina
-
Greater Baltimore Medical CenterWithdrawnCancer | Patients With Clinical and Environmental Risk Factors for Cancer | Patients With a Suspected or Confirmed Diagnosis of CancerUnited States
-
University Hospital, BordeauxRecruitingCardiac Rehabilitation Program Following the Management of ACS in Patients Presenting With SCADFrance
Clinical Trials on clamping group
-
Eastern Hepatobiliary Surgery HospitalCompletedHepatocellular CarcinomaChina
-
Johns Hopkins UniversityTerminatedPrematurityUnited States
-
Universitätsklinikum KölnCompletedAnemia | Very Low Birth Weight Infant | Placental TransfusionGermany
-
Eastern Hepatobiliary Surgery HospitalCompletedHepatocellular CarcinomaChina
-
Carl Backes, MDChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingCongenital Heart Disease (CHD)United States, Canada
-
Uppsala UniversityUNICEF; Ministry of Health and Population, Nepal; Swedish Society for Medical...CompletedAsphyxia Neonatorum | Neonatal DisorderNepal
-
Sharp HealthCareEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingRespiratory Insufficiency | Hyperoxia | IVH- Intraventricular Hemorrhage | Extreme Prematurity | Hypoxia NeonatalUnited States
-
Uppsala UniversityUNICEF; Ministry of Health and Population, Nepal; The Swedish Society of MedicineCompletedEffect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later NeurodevelopmentAnemia | Iron Deficiency | Neonatal JaundiceNepal
-
Benha UniversityRecruiting
-
University Hospital PadovaCompletedElective Cesarean Section | Umbilical Cord ManagementItaly